HLJ1 is a novel biomarker for colorectal carcinoma progression and overall patient survival. - Wikidata - awgldk - TriplyDB

HLJ1 is a novel biomarker for colorectal carcinoma progression and overall patient survival.

HLJ1 is a novel biomarker for colorectal carcinoma progression and overall patient survival.

http://www.wikidata.org/entity/Q37676730

about

Bioinformatics analysis of dysregulated microRNAs in the nipple discharge of patients with breast cancer The Prognostic Impact of Heat Shock Proteins Expression in Patients with Esophageal Cancer: A Meta-Analysis.Knock-down of Hdj2/DNAJA1 co-chaperone results in an unexpected burst of tumorigenicity of C6 glioblastoma cells.HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer.Genomic characterization of liver metastases from colorectal cancer patients.

P2860

Q33685158-E62421E9-762C-4C17-80CF-2F2BC3C93B6F Q36240119-81ABBFAB-B3FB-414B-9EA4-1D5998A4ACF8 Q37225473-98903012-77BB-4D6D-9688-D2D26C2F35B2 Q38686542-9042C80F-D533-4BE0-9565-A57A08091C59 Q42317553-DED53C3B-460E-4248-AD25-AD6C4374B6EB

P2860

HLJ1 is a novel biomarker for colorectal carcinoma progression and overall patient survival.

http://www.wikidata.org/entity/Q37676730

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

HLJ1 is a novel biomarker for ...... and overall patient survival.

@en

HLJ1 is a novel biomarker for ...... and overall patient survival.

@nl

type

label

HLJ1 is a novel biomarker for ...... and overall patient survival.

@en

HLJ1 is a novel biomarker for ...... and overall patient survival.

@nl

prefLabel

HLJ1 is a novel biomarker for ...... and overall patient survival.

@en

HLJ1 is a novel biomarker for ...... and overall patient survival.

@nl

P1433

Q37676730-7FA285DF-D11D-4309-B7C2-DA51C6524480

P1476

Q37676730-D7D91D36-41C6-44DC-B388-40E190BB41D4

P2093

Q37676730-06F7AB17-9ECE-4EAB-9FCE-7C1290B7B184

Q37676730-207DB99C-2C30-48A8-B490-7D11D3FEF47B

Q37676730-2139612C-7579-4E08-BF8E-D85EEF62C1CB

Q37676730-254A06AD-3968-4634-937D-0C55B9F8DBED

Q37676730-3AD80C75-0E45-4E29-ACBC-47877761EB19

Q37676730-5C850F0C-EC37-44DF-A080-B58D09FFDB24

Q37676730-76E94365-6B65-46DF-B973-985F3BAC3427

Q37676730-B0C153D9-D357-4652-B8B1-3C4C533055B2

Q37676730-D1DE8A6E-1DFB-4B6E-AD8F-8DF4B03F6CE4

P2860

Q37676730-13E2C8D8-7701-492C-8F7A-611CB4276903

Q37676730-205C6DAB-71E2-42E2-A6D5-792DC3BF8C3D

Q37676730-2494AA34-25D9-440E-81C3-6724B8008426

Q37676730-2CFE0962-9405-4ECD-943F-BB11A2D460D5

Q37676730-307E7C4D-ADBF-48E5-B75B-6CB69FD25A86

Q37676730-44C5EBA4-FCD3-4BBD-918B-6B11EE825AAF

Q37676730-470F2A3D-1498-4511-9AD3-E189587E2261

Q37676730-76823E08-083E-4073-874A-F0A0F7B0A7DF

Q37676730-8378BDA4-0777-4562-B2EB-4725B74AD34B

Q37676730-8CB9C09E-D0CF-4EE8-A3A2-6D7FB2E68432

P304

Q37676730-09D6EB52-F5E4-4709-9297-0699DC686628

P31

Q37676730-4D525127-5AB3-47EE-8867-BD6ED96EAB71

P433

Q37676730-0DD9F513-91A3-4338-8387-52801ADEFA27

P478

Q37676730-F6754836-450C-406F-828A-96DDB39DBBE0

P577

Q37676730-A846DE27-724A-476A-8940-18D746D6E950

P698

Q37676730-A24DF129-9442-4A3E-85FE-6C570DCB0B29

P921

Q37676730-146AE886-A433-43E2-998A-19D1902438AB

Q37676730-C8786821-1DDB-40DE-AB7A-20ECADEB055D

P932

Q37676730-6A7EEEE9-3600-4725-9B11-147C7D96EFF3

P1433

International Journal of Clinical and Experimental Pathology

P1476

HLJ1 is a novel biomarker for ...... and overall patient survival.

@en

P2093

Cuiwei Zhang

http://www.w3.org/2001/XMLSchema#string

Jie Zhou

http://www.w3.org/2001/XMLSchema#string

Mingxi Tang

http://www.w3.org/2001/XMLSchema#string

Sibei Ruan

http://www.w3.org/2001/XMLSchema#string

Wenguang Fu

http://www.w3.org/2001/XMLSchema#string

Xia Luo

http://www.w3.org/2001/XMLSchema#string

Xiuli Xiao

http://www.w3.org/2001/XMLSchema#string

Yong Liu

http://www.w3.org/2001/XMLSchema#string

Yuan Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of a new member of DnaJ-like heat shock protein 40 (Hsp40) from human liver

The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion

A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma

Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression.

HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma

Successive action of DnaK, DnaJ and GroEL along the pathway of chaperone-mediated protein folding.

New approaches in angiogenic targeting for colorectal cancer.

Study on the clinical significance of Argonaute2 expression in colonic carcinoma by tissue microarray

Postoperative hyperphosphatemia significantly associates with adverse survival in colorectal cancer patients.

The HLJ1-targeting drug screening identified Chinese herb andrographolide that can suppress tumour growth and invasion in non-small-cell lung cancer.

P304

969-977

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24696714

http://www.w3.org/2001/XMLSchema#string

P921

P932

3971299

http://www.w3.org/2001/XMLSchema#string